Diagnostics Pipeline: To Gain Insight into Haystack MRD Test, Quest Works with City of Hope
New liquid biopsy assay will be used in conjunction with 500 cancer patients currently enrolled in clinical trials
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
New liquid biopsy assay will be used in conjunction with 500 cancer patients currently enrolled in clinical trials
Laboratory leader Ihab Abumuhor discusses recent lab automation-related developments and the keys to successful implementation.
As technology advances and testing demand grows, automation and AI are increasingly making their way into the clinical lab.
Once confined to areas such as pregnancy testing, these assays can now be used to detect STIs and other health issues.
Demand for at-home sample collection and infectious disease testing is at an all-time high—and still growing.
Medical director William G. Finn, MD, discusses key trends, challenges, and opportunities related to the expansion of at-home testing.
Is at-home sample collection the solution to lagging cancer screening uptake—or does this approach introduce a new set of challenges?
Several methods are being developed that improve the ability to rapidly identify organisms and report susceptibility results.
A brief overview of antimicrobial susceptibility testing, current methods used, and new methods on the horizon.
Polygenic risk scores may offer new screening and risk stratification options for cardiovascular disease—but how valuable are they?
A pandemic-related drop in cancer diagnoses could spell long-term trouble for patients and providers.